Scientists find a way to 3D print one pill for all that ails you


Multiple medications with different release times—all in one pill.

Last year, the FDA approved a 3D-printed pill for the first time. And now, researchers from the National University of Singapore (NUS) have developed a method to make 3D printing medicine even better. NUS Chemical and Biomolecular Engineering Assistant Professor Soh Siow Ling, with the help of PhD student Sun Yajuan, created a cheap, simple way to prompt a 3D printer to create multiple medications with different release formulas—all in one pill.

Continue reading… “Scientists find a way to 3D print one pill for all that ails you”


Everyone is on drugs

Full Frame Shot Of Pills

The Psychopharmacology of everyday life.

Everyone is on drugs. I don’t mean the old-fashioned, illegal kind, but the kind made by pharmaceutical companies that come in the form of pills. As a psychoanalyst, I’ve listened to people through the screen of their daily doses; and I’ve listened to them without it. Their natural rhythms certainly change, sometimes very dramatically—I guess that’s the point, isn’t it? I have a great many questions about what happens when a mind—a mind that uniquely structures emotion, interest, excitement, defense, association, memory, and rest—is undercut by medication. In this Faustian bargain, what are we gaining? And what are we sacrificing?

There is new resistance to the easy solution of medicating away psychological problems, because of revelations about addiction and abuse, a better understanding of placebo effects, or, for example, the startling realization that antidepressants, far from saving some teenagers from committing suicide, can sometimes push them to do it, which means that these pills should not be a first line of defense. Perhaps the time is right to return to the conundrum of mind and medicine.

The story of psychopharmacology stretches from the advent of barbiturates at the turn of the century to the discovery in the early 1950s of the first antipsychotic, based on a powerful sedative used for surgical purposes that was described as a “non-permanent pharmacological lobotomy.” This drug, Chlorpromazine, led to the development of most of the drugs used today for psychiatric management. The proliferation of psychiatric medications, ones with supposedly less overt dangers, began in the late 1980s—at the same time, a watershed lawsuit was filed in the UK against the makers of benzodiazepines, a class of drugs used for treating anxiety and other disorders, for knowingly downplaying knowledge of their potential for causing harm. Today, psychopharmacology is a multibillion-dollar industry and an estimated one in six adults in America is on some form of psychiatric medication (a statistic that doesn’t even include the use of sleeping pills, or pain pills, or the off-label use of other medications for psychological purposes).

Continue reading… “Everyone is on drugs”


New 3D printer will combine all your medications in one personalized pill


We increasingly live in an age of personalized health care, where treatment can be tailored to suit individuals on a person-by-person basis. A new 3D printer aims to add another piece to this puzzle, by giving pharmacies the ability to quickly and easily produce custom doses of drugs for patients, based on their specific needs. That means that instead of patients on lots of medication having to remember to take three of one pill, two of another and so on, they could instead receive their required doses in vastly simplified form.

Continue reading… “New 3D printer will combine all your medications in one personalized pill”


IBM’s Watson is finally getting closer to becoming your doctor


IBM’s Watson can beat Ken Jennings at Jeopardy, tell you about your city, and dream up recipes for delectable delicacies. Watson is now doing something even more important than all previous capabilities combined — it’s finally getting closer to becoming your doctor.

Continue reading… “IBM’s Watson is finally getting closer to becoming your doctor”


World’s first 3D-printed drug to blow the field of personalized medicine wide open


3D-printed widgets and other medical novelties clearly illustrate the potential of 3D printing. They are set to radically change the biotech and pharmaceutical industry. With its extreme versatility and inherent ability to customize products, many experts believe that 3D printing will finally blow the field of affordable personalized medicine wide open. Yet so far it’s been mostly hope — and plenty of hype — with little sign that the radical technology might actually become a medical mainstay.


Continue reading… “World’s first 3D-printed drug to blow the field of personalized medicine wide open”


Pharmaceutical Manufacturers Are a Significant Source of Drugs in Drinking Water

geological survey

U.S. Geological Survey hydrologic technicians collect a stream sample. 

A five-year study conducted by U.S. Geological Survey (USGS) researchers has found that pharmaceutical manufacturing facilities are a “significant source” of pharmaceuticals that enter the local environment.


Continue reading… “Pharmaceutical Manufacturers Are a Significant Source of Drugs in Drinking Water”


Insects Could Replace Mice In Drug Testing


A cotton bollworm moth flies off the hand of a technician in a laboratory

Moths, caterpillars and fruit flies could soon take the place of millions of mice used every year by scientists testing drugs, researchers said Tuesday.  Biologists have discovered that certain key cells in mammals and insects react in the same way when attacked by infections and produce similar chemical reactions to fight them off.


Continue reading… “Insects Could Replace Mice In Drug Testing”


New Method Of Analyzing Brain Signals Could Help Stroke Patients

New Method Of Analyzing Brain Signals Could Help Stroke Patients 

This image shows brain activity in a stroke patient before (left) and after (right) two weeks of rehabilitative therapy.

New ways to analyze the brain’s electrical activity might soon help physicians diagnose brain disorders and assess the benefits of treatment. ElMindA, a startup based in Israel, is developing one such system, which it hopes will help doctors diagnose attention-deficit/hyperactivity disorder (ADHD) more objectively and speed up treatment decisions for stroke patients. The company is partnering with pharmaceutical and medical-device companies and expects to have a product ready for clinical use in 18 months.

Continue reading… “New Method Of Analyzing Brain Signals Could Help Stroke Patients”


Mini Submarines To Explore Human Body Nearing Reality

Mini Submarines To Explore Human Body Nearing Reality 


Ever since the 1966 Hollywood movie, doctors have imagined a real-life Fantastic Voyage  a medical vehicle shrunk small enough to “submarine” in and fix faulty cells in the body. Thanks to new research by Tel Aviv University scientists, that reality may be only three years away.

Continue reading… “Mini Submarines To Explore Human Body Nearing Reality”